Cargando…

Ivermectin induced Steven–Johnsons syndrome: case report

BACKGROUND: Stevens–Johnson syndrome is one of the manifestations of mucocutaneous adverse drug reactions. Although antimicrobials are responsible for greater than 50% of these adverse drug reactions, there is no documented case implicating ivermectin as the culprit. CASE SUMMARY: A 38 year old adul...

Descripción completa

Detalles Bibliográficos
Autores principales: Aroke, Desmond, Tchouakam, Diego Nitcheu, Awungia, Alexis Tazinya, Mapoh, Sylvester Yari, Ngassa, Stewart Ndutard, Kadia, Benjamin Momo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422988/
https://www.ncbi.nlm.nih.gov/pubmed/28482929
http://dx.doi.org/10.1186/s13104-017-2500-5
_version_ 1783234877748936704
author Aroke, Desmond
Tchouakam, Diego Nitcheu
Awungia, Alexis Tazinya
Mapoh, Sylvester Yari
Ngassa, Stewart Ndutard
Kadia, Benjamin Momo
author_facet Aroke, Desmond
Tchouakam, Diego Nitcheu
Awungia, Alexis Tazinya
Mapoh, Sylvester Yari
Ngassa, Stewart Ndutard
Kadia, Benjamin Momo
author_sort Aroke, Desmond
collection PubMed
description BACKGROUND: Stevens–Johnson syndrome is one of the manifestations of mucocutaneous adverse drug reactions. Although antimicrobials are responsible for greater than 50% of these adverse drug reactions, there is no documented case implicating ivermectin as the culprit. CASE SUMMARY: A 38 year old adult Cameroonian male presented to our health facility with facial rash, painful oral sores, black eschars on lips and red tearing eyes 3 days following ingestion of ivermectin received during a nationwide anti-filarial campaign. He had no known chronic illness, no known allergies and was not on any medications prior to the campaign. Physical examination revealed discharging erythematous eyes, crusted and blister-like lesions with cracks on his lips and oral mucosa. His laboratory tests were unremarkable but for a positive Human Immunodeficiency Virus (HIV) test. A diagnosis of Ivermectin induced Stevens–Johnson syndrome in a newly diagnosed HIV patient was made. The patient was managed with supportive therapy and the evolution thereafter was favourable. CONCLUSION: Stevens–Johnson syndrome is a potential side effect of ivermectin and susceptibility to this adverse effect may be increased in HIV infection.
format Online
Article
Text
id pubmed-5422988
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54229882017-05-12 Ivermectin induced Steven–Johnsons syndrome: case report Aroke, Desmond Tchouakam, Diego Nitcheu Awungia, Alexis Tazinya Mapoh, Sylvester Yari Ngassa, Stewart Ndutard Kadia, Benjamin Momo BMC Res Notes Case Report BACKGROUND: Stevens–Johnson syndrome is one of the manifestations of mucocutaneous adverse drug reactions. Although antimicrobials are responsible for greater than 50% of these adverse drug reactions, there is no documented case implicating ivermectin as the culprit. CASE SUMMARY: A 38 year old adult Cameroonian male presented to our health facility with facial rash, painful oral sores, black eschars on lips and red tearing eyes 3 days following ingestion of ivermectin received during a nationwide anti-filarial campaign. He had no known chronic illness, no known allergies and was not on any medications prior to the campaign. Physical examination revealed discharging erythematous eyes, crusted and blister-like lesions with cracks on his lips and oral mucosa. His laboratory tests were unremarkable but for a positive Human Immunodeficiency Virus (HIV) test. A diagnosis of Ivermectin induced Stevens–Johnson syndrome in a newly diagnosed HIV patient was made. The patient was managed with supportive therapy and the evolution thereafter was favourable. CONCLUSION: Stevens–Johnson syndrome is a potential side effect of ivermectin and susceptibility to this adverse effect may be increased in HIV infection. BioMed Central 2017-05-08 /pmc/articles/PMC5422988/ /pubmed/28482929 http://dx.doi.org/10.1186/s13104-017-2500-5 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Aroke, Desmond
Tchouakam, Diego Nitcheu
Awungia, Alexis Tazinya
Mapoh, Sylvester Yari
Ngassa, Stewart Ndutard
Kadia, Benjamin Momo
Ivermectin induced Steven–Johnsons syndrome: case report
title Ivermectin induced Steven–Johnsons syndrome: case report
title_full Ivermectin induced Steven–Johnsons syndrome: case report
title_fullStr Ivermectin induced Steven–Johnsons syndrome: case report
title_full_unstemmed Ivermectin induced Steven–Johnsons syndrome: case report
title_short Ivermectin induced Steven–Johnsons syndrome: case report
title_sort ivermectin induced steven–johnsons syndrome: case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422988/
https://www.ncbi.nlm.nih.gov/pubmed/28482929
http://dx.doi.org/10.1186/s13104-017-2500-5
work_keys_str_mv AT arokedesmond ivermectininducedstevenjohnsonssyndromecasereport
AT tchouakamdiegonitcheu ivermectininducedstevenjohnsonssyndromecasereport
AT awungiaalexistazinya ivermectininducedstevenjohnsonssyndromecasereport
AT mapohsylvesteryari ivermectininducedstevenjohnsonssyndromecasereport
AT ngassastewartndutard ivermectininducedstevenjohnsonssyndromecasereport
AT kadiabenjaminmomo ivermectininducedstevenjohnsonssyndromecasereport